Table of Content

1. Introduction
1.1 The Insight Partners Research Report Guidance.
1.2 Market Segmentation.

2. Executive Summary
2.1 Key Insights.

3. Research Methodology
3.1 Secondary Research.
3.2 Primary Research.
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.1 Developing base number:
3.2.2 Data Triangulation:
3.2.3 Country level data:

4. Small Molecule Drug Discovery Market Landscape
4.1 Overview.
4.2 PEST Analysis.

5. Small Molecule Drug Discovery Market – Key Market Dynamics
5.1 Small Molecule Drug Discovery Market – Key Market Dynamics.
5.2 Market Drivers.
5.2.1 Flourishing Pharmaceutical Industry with Surge in R&D Activities.
5.2.2 Growing Inclination Toward Outsourcing.
5.3 Market Restraints.
5.3.1 High Drug Development Cost
5.4 Market Opportunities.
5.4.1 Increasing Small Molecule-Based Pipeline.
5.5 Future Trends.
5.5.1 Growing Adoption of Artificial Intelligence in Drug Discovery.
5.6 Impact of Drivers and Restraints:

6. Small Molecule Drug Discovery Market – Global Market Analysis
6.1 Small Molecule Drug Discovery Market Revenue (US$ Million), 2021–2031.
6.2 Small Molecule Drug Discovery Market Forecast Analysis.

7. Small Molecule Drug Discovery Market Analysis – by Therapeutic Area
7.1 Oncology.
7.1.1 Overview.
7.1.2 Oncology: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Central Nervous System..
7.2.1 Overview.
7.2.2 Central Nervous System: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Cardiovascular
7.3.1 Overview.
7.3.2 Cardiovascular: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Respiratory.
7.4.1 Overview.
7.4.2 Respiratory: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Orthopedics.
7.5.1 Overview.
7.5.2 Orthopedics: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Immunology.
7.6.1 Overview.
7.6.2 Immunology: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Rare Diseases.
7.7.1 Overview.
7.7.2 Rare Diseases: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Other Therapeutic Areas.
7.8.1 Overview.
7.8.2 Other Therapeutic Areas: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)

8. Small Molecule Drug Discovery Market Analysis – by Process or Phase
8.1 Target Discovery.
8.1.1 Overview.
8.1.2 Target Discovery: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Target Validation.
8.2.1 Overview.
8.2.2 Target Validation: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Lead Generation and Refinement
8.3.1 Overview.
8.3.2 Lead Generation and Refinement: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Preclinical Development
8.4.1 Overview.
8.4.2 Preclinical Development: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)

9. Small Molecule Drug Discovery Market – Geographical Analysis
9.1 North America.
9.1.1 North America Small Molecule Drug Discovery Market Overview.
9.1.2 North America: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.1.3 North America: Small Molecule Drug Discovery Market – Revenue and Forecast Analysis – by Therapeutic Area.
9.1.4 North America: Small Molecule Drug Discovery Market – Revenue and Forecast Analysis – by Process or Phase.
9.1.5 North America: Small Molecule Drug Discovery Market – Revenue and Forecast Analysis – by Country.
9.1.5.1 United States: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.1.5.1.1 United States: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
9.1.5.1.2 United States: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
9.1.5.2 Canada: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.1.5.2.1 Canada: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
9.1.5.2.2 Canada: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
9.1.5.3 Mexico: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.1.5.3.1 Mexico: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
9.1.5.3.2 Mexico: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
9.2 Europe
9.2.1 Europe Small Molecule Drug Discovery Market Overview.
9.2.2 Europe: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.2.3 Europe: Small Molecule Drug Discovery Market – Revenue and Forecast Analysis – by Therapeutic Area.
9.2.4 Europe: Small Molecule Drug Discovery Market – Revenue and Forecast Analysis – by Process or Phase.
9.2.5 Europe: Small Molecule Drug Discovery Market – Revenue and Forecast Analysis – by Country.
9.2.5.1 Germany: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.2.5.1.1 Germany: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
9.2.5.1.2 Germany: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
9.2.5.2 France: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.2.5.2.1 France: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
9.2.5.2.2 France: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
9.2.5.3 United Kingdom: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.2.5.3.1 United Kingdom: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
9.2.5.3.2 United Kingdom: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
9.2.5.4 Italy: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.2.5.4.1 Italy: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
9.2.5.4.2 Italy: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
9.2.5.5 Spain: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.2.5.5.1 Spain: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
9.2.5.5.2 Spain: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
9.2.5.6 Rest of Europe: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.2.5.6.1 Rest of Europe: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
9.2.5.6.2 Rest of Europe: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
9.3 Asia Pacific.
9.3.1 Asia Pacific Small Molecule Drug Discovery Market Overview.
9.3.2 Asia Pacific: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.3.3 Asia Pacific: Small Molecule Drug Discovery Market – Revenue and Forecast Analysis – by Therapeutic Area.
9.3.4 Asia Pacific: Small Molecule Drug Discovery Market – Revenue and Forecast Analysis – by Process or Phase.
9.3.5 Asia Pacific: Small Molecule Drug Discovery Market – Revenue and Forecast Analysis – by Country.
9.3.5.1 Japan: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.3.5.1.1 Japan: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
9.3.5.1.2 Japan: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
9.3.5.2 China: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.3.5.2.1 China: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
9.3.5.2.2 China: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
9.3.5.3 India: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.3.5.3.1 India: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
9.3.5.3.2 India: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
9.3.5.4 South Korea: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.3.5.4.1 South Korea: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
9.3.5.4.2 South Korea: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
9.3.5.5 Australia: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.3.5.5.1 Australia: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
9.3.5.5.2 Australia: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
9.3.5.6 Rest of APAC: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.3.5.6.1 Rest of APAC: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
9.3.5.6.2 Rest of APAC: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
9.4 Middle East & Africa.
9.4.1 Middle East & Africa Small Molecule Drug Discovery Market Overview.
9.4.2 Middle East & Africa: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.4.3 Middle East & Africa: Small Molecule Drug Discovery Market – Revenue and Forecast Analysis – by Therapeutic Area.
9.4.4 Middle East & Africa: Small Molecule Drug Discovery Market – Revenue and Forecast Analysis – by Process or Phase.
9.4.5 Middle East & Africa: Small Molecule Drug Discovery Market – Revenue and Forecast Analysis – by Country.
9.4.5.1 Saudi Arabia: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.4.5.1.1 Saudi Arabia: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
9.4.5.1.2 Saudi Arabia: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
9.4.5.2 United Arab Emirates: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.4.5.2.1 United Arab Emirates: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
9.4.5.2.2 United Arab Emirates: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
9.4.5.3 South Africa: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.4.5.3.1 South Africa: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
9.4.5.3.2 South Africa: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
9.4.5.4 Rest of Middle East & Africa: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.4.5.4.1 Rest of Middle East & Africa: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
9.4.5.4.2 Rest of Middle East & Africa: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
9.5 South & Central America.
9.5.1 South & Central America Small Molecule Drug Discovery Market Overview.
9.5.2 South & Central America: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.5.3 South & Central America: Small Molecule Drug Discovery Market – Revenue and Forecast Analysis – by Therapeutic Area.
9.5.4 South & Central America: Small Molecule Drug Discovery Market – Revenue and Forecast Analysis – by Process or Phase.
9.5.5 South & Central America: Small Molecule Drug Discovery Market – Revenue and Forecast Analysis – by Country.
9.5.5.1 Brazil: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.5.5.1.1 Brazil: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
9.5.5.1.2 Brazil: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
9.5.5.2 Argentina: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.5.5.2.1 Argentina: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
9.5.5.2.2 Argentina: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
9.5.5.3 Rest of South & Central America: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
9.5.5.3.1 Rest of South & Central America: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
9.5.5.3.2 Rest of South & Central America: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.

10. Industry Landscape
10.1 Overview.

11. Company Profiles
11.1 Bristol-Myers Squibb Co.
11.1.1 Key Facts.
11.1.2 Business Description.
11.1.3 Products and Services.
11.1.4 Financial Overview.
11.1.5 SWOT Analysis.
11.1.6 Key Developments.
11.2 Merck KGaA.
11.2.1 Key Facts.
11.2.2 Business Description.
11.2.3 Products and Services.
11.2.4 Financial Overview.
11.2.5 SWOT Analysis.
11.2.6 Key Developments.
11.3 GSK Plc.
11.3.1 Key Facts.
11.3.2 Business Description.
11.3.3 Products and Services.
11.3.4 Financial Overview.
11.3.5 SWOT Analysis.
11.3.6 Key Developments.
11.4 Thermo Fisher Scientific Inc.
11.4.1 Key Facts.
11.4.2 Business Description.
11.4.3 Products and Services.
11.4.4 Financial Overview.
11.4.5 SWOT Analysis.
11.4.6 Key Developments.
11.5 ICON Plc.
11.5.1 Key Facts.
11.5.2 Business Description.
11.5.3 Products and Services.
11.5.4 Financial Overview.
11.5.5 SWOT Analysis.
11.5.6 Key Developments.
11.6 Danaher Corp.
11.6.1 Key Facts.
11.6.2 Business Description.
11.6.3 Products and Services.
11.6.4 Financial Overview.
11.6.5 SWOT Analysis.
11.6.6 Key Developments.
11.7 Charles River Laboratories International Inc.
11.7.1 Key Facts.
11.7.2 Business Description.
11.7.3 Products and Services.
11.7.4 Financial Overview.
11.7.5 SWOT Analysis.
11.7.6 Key Developments.
11.8 Oncodesign Services.
11.8.1 Key Facts.
11.8.2 Business Description.
11.8.3 Products and Services.
11.8.4 Financial Overview.
11.8.5 SWOT Analysis.
11.8.6 Key Developments.
11.9 Revvity Inc.
11.9.1 Key Facts.
11.9.2 Business Description.
11.9.3 Products and Services.
11.9.4 Financial Overview.
11.9.5 SWOT Analysis.
11.9.6 Key Developments.
11.10 Boehringer Ingelheim International GmbH.
11.10.1 Key Facts.
11.10.2 Business Description.
11.10.3 Products and Services.
11.10.4 Financial Overview.
11.10.5 SWOT Analysis.
11.10.6 Key Developments.

12. Appendix
12.1 About The Insight Partners.
12.2 Glossary of Terms.



List of Figures

LIST OF FIGURES

Figure 1. Small Molecule Drug Discovery Market Segmentation, by Geography.
Figure 2. PEST Analysis.
Figure 3. Impact Analysis of Drivers and Restraints.
Figure 4. Small Molecule Drug Discovery Market Revenue (US$ Million), 2021–2031.
Figure 5. Small Molecule Drug Discovery Market Share (%) – by Therapeutic Area (2023 and 2031)
Figure 6. Oncology: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Central Nervous System: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Cardiovascular: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Respiratory: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Orthopedics: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Immunology: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Rare Diseases: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Other Therapeutic Areas: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Small Molecule Drug Discovery Market Share (%) – by Process or Phase (2023 and 2031)
Figure 15. Target Discovery: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Target Validation: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Lead Generation and Refinement: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Preclinical Development: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. North America: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 20. North America: Small Molecule Drug Discovery Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 21. United States: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 22. Canada: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 23. Mexico: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 24. Europe: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 25. Europe: Small Molecule Drug Discovery Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. Germany: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 27. France: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 28. United Kingdom: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 29. Italy: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 30. Spain: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 31. Rest of Europe: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 32. Asia Pacific: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 33. Asia Pacific: Small Molecule Drug Discovery Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 34. Japan: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 35. China: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 36. India: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 37. South Korea: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 38. Australia: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 39. Rest of APAC: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 40. Middle East & Africa: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 41. Middle East & Africa: Small Molecule Drug Discovery Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 42. Saudi Arabia: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 43. United Arab Emirates: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 44. South Africa: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 45. Rest of Middle East & Africa: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
Figure 46. South & Central America: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 47. South & Central America: Small Molecule Drug Discovery Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 48. Brazil: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 49. Argentina: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million)
Figure 50. Rest of South & Central America: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)

List of Tables

LIST OF TABLES

Table 1. Small Molecule Drug Discovery Market Segmentation.
Table 2. R&D Investments by Major Pharmaceutical Companies.
Table 3. Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)
Table 4. North America: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 5. North America: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 6. United States: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 7. United States: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 8. Canada: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 9. Canada: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 10. Mexico: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 11. Mexico: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 12. Europe: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 13. Europe: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 14. Germany: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 15. Germany: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 16. France: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 17. France: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 18. United Kingdom: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 19. United Kingdom: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 20. Italy: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 21. Italy: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 22. Spain: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 23. Spain: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 24. Rest of Europe: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 25. Rest of Europe: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 26. Asia Pacific: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 27. Asia Pacific: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 28. Japan: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 29. Japan: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 30. China: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 31. China: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 32. India: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 33. India: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 34. South Korea: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 35. South Korea: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 36. Australia: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 37. Australia: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 38. Rest of APAC: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 39. Rest of APAC: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 40. Middle East & Africa: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 41. Middle East & Africa: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 42. Saudi Arabia: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 43. Saudi Arabia: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 44. United Arab Emirates: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 45. United Arab Emirates: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 46. South Africa: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 47. South Africa: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 48. Rest of Middle East & Africa: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Area.
Table 49. Rest of Middle East & Africa: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 50. South & Central America: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 51. South & Central America: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 52. Brazil: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 53. Brazil: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 54. Argentina: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 55. Argentina: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Process or Phase.
Table 56. Rest of South & Central America: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031(US$ Million) – by Therapeutic Area.
Table 57. Rest of South & Central America: Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million) – by Process or Phase.
Table 58. Recent Inorganic Growth Strategies in the Small Molecule Drug Discovery Market
Table 59. Glossary of Terms, Small Molecule Drug Discovery Market